Markets:

Overview

News

Currencies

International

Treasuries

Shockwave Medical, Inc. - Common Stock (NQ:SWAV)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Benzinga's After-Hours Earnings Roundup: Roku, Shake Shack, Dropbox And More ↗

February 17, 2022

Benzinga’s after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details. The list is handpicked by the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 17, 2022

Gainers Creative Medical Tech (NASDAQ:CELZ

Via Benzinga

ShockWave Medical: Q4 Earnings Insights ↗

February 17, 2022

ShockWave Medical (NASDAQ:SWAV) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 17, 2022 ↗

February 17, 2022

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.

Via Benzinga

ShockWave Medical's Earnings: A Preview ↗

February 16, 2022

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that ShockWave...

Via Benzinga

Analyst Ratings For ShockWave Medical ↗

January 07, 2022

ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings ...

Via Benzinga

20 Stocks Moving in Monday's Pre-Market Session ↗

January 10, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) rose 32.1% to $4.53 in pre-market trading. Pluristem Therapeutics Inc. (NASDAQ: PSTI) rose 28.5% to $1.89 in pre-...

Via Benzinga

Penumbra Weighs Combination With Shockwave Medical: Bloomberg ↗

January 10, 2022

Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the...

Via Benzinga

ShockWave Medical Inc (SWAV) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

SWAV earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

ShockWave Medical: Q3 Earnings Insights ↗

November 08, 2021

ShockWave Medical (NASDAQ:SWAV) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Outlook For ShockWave Medical ↗

November 05, 2021

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021 ↗

December 06, 2021

Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:

Via Benzinga

Shockwave IVL Shows Consistent Treatment Of Calcium In Real-World Study ↗

October 06, 2021

Shockwave Medical Inc (NASDAQ: SWAV) has announced interim analysis from the Disrupt PAD III Observational Study evaluating the Intravascular Lithotripsy (IVL)...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Shockwave Medical Insider Trades $877 Thousand In Company Stock ↗

September 24, 2021

Frank T Watkins, Director at Shockwave Medical (NASDAQ:SWAV), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S...

Via Benzinga

Topics Regulatory Compliance

Earnings Scheduled For November 8, 2021 ↗

November 08, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Why Did Shockwave Medical Stock Gain 18% in August? ↗

September 07, 2021

The medical device stock is growing even quicker than investors anticipated.

Via The Motley Fool

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

August 25, 2021

Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs. Facts of Interest: The largest company by market cap to set a new 52-week high was Alphabet (...

Via Benzinga

This Healthcare Stock Grew Revenue by More Than 400% in the Second Quarter ↗

August 25, 2021

Here's one innovative company you might want to put on your radar.

Via The Motley Fool

ShockWave Medical Inc (SWAV) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

SWAV earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Why Shockwave Medical Surged as High as 10% Today ↗

August 09, 2021

Top- and bottom-line beats plus raised guidance made for a very healthy stock on Monday.

Via The Motley Fool

Shockwave Medical Reports Narrower Than Expected Q2 Loss; Guides Above Consensus ↗

August 09, 2021

Shockwave Medical Inc's (NASDAQ: SWAV) second-quarter FY21 sales were up 4-fold to $55.9 million beating the Wall Street consensus of $45.17 million. The...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 09, 2021

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The company's market cap stands at $61.9 million. The...

Via Benzinga

ShockWave Medical: Q2 Earnings Insights ↗

August 09, 2021

Shares of ShockWave Medical (NASDAQ:SWAV) moved higher by 0.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 98....

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.